SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-185670
Filing Date
2023-07-12
Accepted
2023-07-12 08:05:53
Documents
17
Period of Report
2023-07-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d534607d8k.htm   iXBRL 8-K 43097
2 EX-5.1 d534607dex51.htm EX-5.1 14139
3 EX-99.1 d534607dex991.htm EX-99.1 18136
7 GRAPHIC g534607g0712060921020.jpg GRAPHIC 1689
8 GRAPHIC g534607g07d14.jpg GRAPHIC 3456
9 GRAPHIC g534607g90w23.jpg GRAPHIC 3363
  Complete submission text file 0001193125-23-185670.txt   220061

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20230712.xsd EX-101.SCH 2865
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20230712_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20230712_pre.xml EX-101.PRE 10822
11 EXTRACTED XBRL INSTANCE DOCUMENT d534607d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 231083282
SIC: 3841 Surgical & Medical Instruments & Apparatus